These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1638119)

  • 41. Methylation-sensitive DNA binding by v-myb and c-myb proteins.
    Klempnauer KH
    Oncogene; 1993 Jan; 8(1):111-5. PubMed ID: 8423989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of Myb proteins in normal and neoplastic cell proliferation.
    Lyon J; Robinson C; Watson R
    Crit Rev Oncog; 1994; 5(4):373-88. PubMed ID: 7711114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis.
    Caracciolo D; Venturelli D; Valtieri M; Peschle C; Gewirtz AM; Calabretta B
    J Clin Invest; 1990 Jan; 85(1):55-61. PubMed ID: 2404028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene.
    Introna M; Golay J; Frampton J; Nakano T; Ness SA; Graf T
    Cell; 1990 Dec; 63(6):1289-97. PubMed ID: 2261644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Biochemistry and structural biology in the post-genome era: search for the underlying mechanisms of biological molecules].
    Ogata K
    Seikagaku; 2004 Oct; 76(10):1305-19. PubMed ID: 15580862
    [No Abstract]   [Full Text] [Related]  

  • 47. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of human hematopoietic tumor formation by targeting a repressor Myb-KRAB to DNA.
    Nawrath M; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 Jun; 7(6):963-72. PubMed ID: 10880029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation.
    Sandberg ML; Sutton SE; Pletcher MT; Wiltshire T; Tarantino LM; Hogenesch JB; Cooke MP
    Dev Cell; 2005 Feb; 8(2):153-66. PubMed ID: 15691758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
    Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
    Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory interaction of c-Myb and GATA-1 via transcriptional co-activator CBP.
    Takahashi T; Suwabe N; Dai P; Yamamoto M; Ishii S; Nakano T
    Oncogene; 2000 Jan; 19(1):134-40. PubMed ID: 10644988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb.
    Szczylik C; Skorski T; Ku DH; Nicolaides NC; Wen SC; Rudnicka L; Bonati A; Malaguarnera L; Calabretta B
    J Exp Med; 1993 Sep; 178(3):997-1005. PubMed ID: 7688794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-function studies of ETS transcription factors.
    Mimeault M
    Crit Rev Oncog; 2000; 11(3-4):227-53. PubMed ID: 11358268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. c-myb and growth control.
    Calabretta B; Nicolaides NC
    Crit Rev Eukaryot Gene Expr; 1992; 2(3):225-35. PubMed ID: 1511186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development.
    Sakamoto H; Dai G; Tsujino K; Hashimoto K; Huang X; Fujimoto T; Mucenski M; Frampton J; Ogawa M
    Blood; 2006 Aug; 108(3):896-903. PubMed ID: 16597594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
    Boise LH; Gorse KM; Westin EH
    Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.
    Ness SA; Kowenz-Leutz E; Casini T; Graf T; Leutz A
    Genes Dev; 1993 May; 7(5):749-59. PubMed ID: 7684005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vintage reds and whites: combinatorial transcription factor utilization in hematopoietic differentiation.
    Ness SA; Engel JD
    Curr Opin Genet Dev; 1994 Oct; 4(5):718-24. PubMed ID: 7849512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain.
    Ganter B; Fu Sl; Lipsick JS
    EMBO J; 1998 Jan; 17(1):255-68. PubMed ID: 9427759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional trans-repression by the c-myb proto-oncogene product.
    Nakagoshi H; Nagase T; Ueno Y; Ishii S
    Nucleic Acids Res; 1989 Sep; 17(18):7315-24. PubMed ID: 2552408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.